With an aim to become the number 1 hotspot for global bioscience industry in Asia, Singapore has committed $13.05 billion (S$16.1 billion) in continued support of... Read more
Malaysia is now emerging as a manufacturing hub for international pharmaceutical companies and provides them smooth passage to set up manufacturing plants. The country... Read more
Leveraging on the back of increasing sales of generic medicines, continued growth in chronic therapies and a greater penetration in rural markets, the Indian pharmaceutical... Read more
Increase in aging population along with rising burden of non communicable diseases in Australia have been putting pressure on the government to offer drugs at affordable... Read more
Biopharma firms, which are located on the western part of the globe, are keeping a close watch on the dragon nation, with hopes that they can leverage on the potential... Read more
Indian apex court has made its intentions clear with the rejection of Novartis' plea to obtain patent protection for cancer drug Glivec in India. The Supreme Court... Read more
Steering Bionomics' focus towards large markets where there is a defined clinical need for new treatments, Dr Rathjen helped it gain global recognition for its multiple... Read more
A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundation (CARIF), a non-profit cancer research institute... Read more
Chinese vaccine development companies are raising the bar to meet international standards. However, access to foreign markets remains a challenge. Shanghai BravoBio,... Read more
Prof Mark Kendall, a scientist at the Australian Institute of Bioengineering and Nanotechnology under University of Queensland, came up with the idea of nanopatch... Read more
The present chairman of Singapore's Biomedical Research Council (BMRC) Prof Sir George Radda has changed the way universities in Singapore approach the research... Read more
Development of stem cell therapies requires innovative technologies and processes to overcome safety concerns and VeriStem Technologies of Singapore aims to fulfil... Read more
Fostering scientific developments in genomics study is not comprehensive enough to integrate personalized medicine into clinical application unless the regulatory... Read more
Singapore: Health Sciences Authority (HSA), which is the national regulator for health products in Singapore, inaugurated the Asia Regulatory Conference 2013 in... Read more
Singapore: The three-day Asia Regulatory Conference 2013 is under way at the Raffles City Convention Center, Singapore, with much pomp and grandeur. The event, which... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
